Management of thyroid carcinoma in children and young adults

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue SUPPL. 2, 2012, Pages

  Rapkin, Louis ^a   Pashankar, Farzana D ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; follicular; guidelines; medullary; Papillary; thyroid; treatment

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; IODINE 131; LIOTHYRONINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN; THYROXINE; VANDETANIB;

ADULT; AGE DISTRIBUTION; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER REGRESSION; CANCER SCREENING; CANCER STAGING; CERVICAL LYMPHADENOPATHY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DIFFERENTIATED THYROID CANCER; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG ERUPTION; DRUG INDUCED HEADACHE; ECHOGRAPHY; EUTHYROIDISM; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOPARATHYROIDISM; LONG TERM SURVIVAL; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MUTATIONAL ANALYSIS; NAUSEA; NECK DISSECTION; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIOACTIVE IODINE ABLATION; RECURRENT LARYNGEAL NERVE INJURY; REVIEW; SIPPLE SYNDROME; SUBTOTAL THYROIDECTOMY; THYROID MASS; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROIDECTOMY; TUMOR ABLATION; TUMOR RECURRENCE;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IODINE ISOTOPES; MALE; PIPERIDINES; QUINAZOLINES; THYROID NEOPLASMS; THYROTROPIN; YOUNG ADULT;

EID: 84860271220     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31824e37a6     Document Type: Review

References (61)

1. Bernstein L, Gurney JG. Carcinomas and other malignant epithelial neoplasms. ICCC XI. Pediatric Monograph, NCI SEER., 2001.
2. Waguespack S, Wells S, Ross J, et al. Thyroid Cancer, SEER AYA Monograph. Halac I, Zimmerman D. Thyroid nodules and cancers in children. Endocrinol Metab Clin North Am. 2005;34:725-744.
3. Rachmiel M, Charron M, Gupta A, et al. Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma. J Pediatr Endocrinol Metab. 2006;19:1377-1393. (Pubitemid 46043769)
4. Cotterill SJ, Pearce MS, Parker L. Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident? Eur J Cancer. 2001;37:1020-1026. (Pubitemid 32397688)
5. Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid. 2002;12:683-702. (Pubitemid 34913241)
6. Skinner MA, DeBenedetti MK, Moley JF, et al. Medullary thyroid carcinoma in children with multiple endocrine neo-plasia types 2A and 2B. J Pediatr Surg. 1996;31:177-181; discussion 181-182.
7. Brauckhoff M, Gimm O, Weiss CL, et al. Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World JSurg. 2004;28:1305-1311. (Pubitemid 40941297)
8. Skinner MA. Management of hereditary thyroid cancer in children. Surg Oncol. 2003;12:101-104. (Pubitemid 37289015)
9. Feinmesser R, Lubin E, Segal K, et al. Carcinoma of the thyroid in children\a review. J Pediatr Endocrinol Metab. 1997;10:561-568.
10. Anso GE, Domene HM, Garcia R, et al. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Cancer. 2002;94:323-330. (Pubitemid 34081360)
11. Alsanea O, Clark OH. Familial thyroid cancer. Curr Opin Oncol. 2001;13:44-51. (Pubitemid 32060043)
12. Fitze G. Management of patients with hereditary medullary thyroid carcinoma. Eur JPediatr Surg. 2004;14:375-383. (Pubitemid 40070312)
13. Hill CS, Ibanez ML, Samaan NA, et al. Medullary (solid) carcinoma of the thyroid gland: an analysis of the M.D. Anderson Hospital experience with patients with the tumor, its special features, and its histogenesis. Medicine. 1973;52:141-171
14. Harac HR, Williams ED. Childhood thyroid cancer in England and Wales. Br J Cancer. 1995;72:777-783.
15. Arici C, Erdogan O, Altunbas H, et al. Differentiated thyroid carcinoma in children and adolescents. Clinical characteristics, treatment and outcome of 15 patients. Horm Res. 2002;57: 153-156. (Pubitemid 34621645)
16. Grigsby PW, Gal-or A, Michalski JM, et al. Childhood and adolescent thyroid carcinoma. Cancer. 2002;95:724-729. (Pubitemid 34839662)
17. Shapiro NL, Bhattacharyya N. Population-based outcomes for pediatric thyroid carcinoma. Laryngoscope. 2005;115: 337-340. (Pubitemid 40216715)
18. Thompson GB, Hay ID. Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma. WorldJSurg. 2004;28:1187-1198. (Pubitemid 40941277)
19. Harness JK, Sahar DE, et al. Childhood thyroid carcinoma. In: Clark O, Duh Q-Y, Kebebew E, eds. Textbook of Endocrine Surgery. 2nd ed. Philadelphia, PA: Elsevier Saunders Company; 2005:93-101.
20. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer. 2006;13:427-453. (Pubitemid 43886667)
21. Zimmerman D, Hay ID, Gough IR, et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery. 1988;104:1157-1166. (Pubitemid 19012000)
22. O'Riordain DS, O'Brien T, Crotty TB, et al. Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery. 1995;118:936-942.
23. Norton JA, Froome LC, Farrell RE, et al. Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma. Surg Clin North Am. 1979;59:109-118. (Pubitemid 9170820)
24. Samaan NA, Draznin MB, Halpin RE, et al. Multiple endocrine syndrome type IIb in early childhood. Cancer. 1991;68:1832-1834.
25. Ball DW. Medullary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am. 2007;36:23-37.
26. Moon WJ, Jung SL, Lee JH, et al. Benign and malignant thyroid nodules: US differentiation\multicenter retrospective study. Radiology. 2008;247:762-770.
27. Stevens C, Lee JKP, Sadatsafavi M, et al. Pediatric thyroid fine needle aspiration cytology: a meta-analysis. J Pediatr Surg. 2009;44:2184-2191.
28. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
29. Jameson JL, Weetman AP. Disorders of the thyroid gland. In: Fauci AS, Braunwald E, Kasper DL, eds. Harrison's Online. 7th ed McGraw-Hill Co. Inc.; 2008.
30. Weber T, Schilling T, Buchler MW. Thyroid carcinoma. Curr Opin Oncol. 2006;18:30-35 (Pubitemid 43740447)
31. Canadian Pediatric Thyroid Nodule Study Group. The Canadian Pediatric Thyroid Nodule Study: an evaluation of current management practices. J Ped Surg. 2008;43:826-830.
32. Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. Clin Endo Metab. 2010;95:2655-2663.
33. Jimenez C, Hu MI, Gagel RF. Management ofmedullary thyroid carcinoma. Endocrinol Metab Clin North Am. 2008;37:481-496.
34. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-5671. (Pubitemid 33152604)
35. La Quaglia MP, Black T, Holcomb GW III, et al. Differ-entiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg. 2000;35:955-959; discussion 960.
36. Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Handbook. 7th ed. NY: Springer Verlag; 2010.
37. Cobin RH, Gharib H, Bergman DA, et al. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract. 2001;7:203-220.
38. Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience oftreating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Clim Assoc. 2002; 113:241-260.
39. Thyroid carcinoma. NCCN practice guidelines. v.1., 2005.
40. Jarzab B, Handkiewicz Junak D, Wloch J, et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med. 2000;27:833-841. (Pubitemid 30456766)
41. Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg. 1998; 227:533-541. (Pubitemid 28363270)
42. Dinauer CA, Tuttle RM, Robie DK, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol. 1997;49:619-628. (Pubitemid 28529761)
43. Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differ-entiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer. 2005; 12:773-803. (Pubitemid 41815776)
44. Hay ID, Gonzolez-Losada T, Reinalda MS, et al. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg. 2010;34:1192-1202.
45. Serhal DI, Nasrallah MP, Arafah BM. Rapid rise in serum thyrotropin concentrations after thyroidectomy of withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differ-entiated thyroid cancer. J Clin Endocrinol Metab. 2004;89: 3285-3289. (Pubitemid 38951894)
46. Luster M, Handkiewicz-Junak D, Grossi A, et al. Recombinant tyrotropin use in children and adolescents with differentiated thyroid cancer. J Clin Endocrinol Metab. 2009;94:3948-3953.
47. Franzius C, Dietlein M, Biermann M, et al. Procedure guideline for radioiodine therapy and 131 iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer. Nuklearmedizin. 2007;46:224-231. (Pubitemid 47612290)
48. Hovens GC, Stokkel MP, Kievit J, et al. Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab. 2007; 92:2610-2615. (Pubitemid 47037365)
49. Landau D, Vini L, A'Hern R, et al. Thyroid cancer in children: the Royal Marsden Hospital experience. Europ J Cancer. 2000;36:214-220. (Pubitemid 30102198)
50. Segni M, Gorman CA. The aftermath ofchildhood hyperthyro-idism. JPediatr Endocrinol Metab. 2001;14(suppl 5):1277-1282.
51. Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19:565-612.
52. Sippel RS, Kunnimalaiyaan M, Chen H. Current management ofmedullary thyroid cancer. Oncologist. 2008;13:539-547. (Pubitemid 351872871)
53. Moore SW, Zaahl MG. Multiple endocrine neoplasia syn-dromes, children, Hirschsprung's disease and RET. Pediatr Surg Int. 2008;24:521-530.
54. Punales MKC, Possatti da Rocha A, Meotti C, et al. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A. Thyroid. 2008;18:1261-1268.
55. Pelizzo MR, Boschin IM, Bernante P, et al. Natural history, diagnosis, treatment and outcome ofmedullary thyroid cancer: 37 years experience on 157 patients. Eur J Surg Oncol. 2007;33:493-497. (Pubitemid 46586095)
56. Hyer SL, Vini L, A'Hern R, et al. Medullary thyroid cancer: multivariate analysis ofprognostic factors influencing survival. Eur J Surg Oncol. 2000;26:686-690.
57. Wells SA Jr, Robinson BG, Gagel RF, et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double blind phase III trial. J Clin Oncol. 2012;30:134-141.
58. Sherman SI. Early clinical studies ofnovel therapies for thyroid cancers. Endocrinol Metab Clin North Am. 2008;37:511-524. (Pubitemid 351698088)
59. Luster M, Lassmann M, Freudenberg LS, et al. Thyroid cancer in childhood: management strategy, including dosimetry and long-term results. Hormones. 2007;6:269-278.
60. Franc S, Niccoli-Sire P, Cohen R, et al. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma. Clin Endocrinol (Oxf). 2001;55: 403-409. (Pubitemid 32823051)
61. Brignardello E, Corrias A, Isolato G, et al. Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series. J Clin Endocrin Metab. 2008;93:4840-4843.